Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (491-500 of 504) with videos related to

Pageof 51
Sort By:
Cancer Discovery|October 16, 2020
Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of OriginElisa Espinet, Zuguang Gu, Charles D Imbusch, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
International Journal of Cancer|April 23, 2019
Variant classification in precision oncologyJonas Leichsenring, Peter Horak, Simon Kreutzfeldt, et al.
JCO Precision Oncology|February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research ExperienceAmelie Lier, Roland Penzel, Christoph Heining, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Latent plasticity of the human pancreas across development, health, and diseaseElisabetta Mereu, Diego Balboa, Johannes Liebig, et al.
JCI Insight|July 3, 2020
Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncologyZahra Dantes, Hsi-Yu Yen, Nicole Pfarr, et al.
Nature|January 25, 2018
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Thomas Engleitner, Roman Maresch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcomaChristoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2022
Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinomaPaula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, et al.
Pageof 51

Showing results (491-500 of 504) with videos related to

Sort By:
Pageof 51
Cancer Discovery|October 16, 2020
Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of OriginElisa Espinet, Zuguang Gu, Charles D Imbusch, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
International Journal of Cancer|April 23, 2019
Variant classification in precision oncologyJonas Leichsenring, Peter Horak, Simon Kreutzfeldt, et al.
JCO Precision Oncology|February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research ExperienceAmelie Lier, Roland Penzel, Christoph Heining, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Latent plasticity of the human pancreas across development, health, and diseaseElisabetta Mereu, Diego Balboa, Johannes Liebig, et al.
JCI Insight|July 3, 2020
Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncologyZahra Dantes, Hsi-Yu Yen, Nicole Pfarr, et al.
Nature|January 25, 2018
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Thomas Engleitner, Roman Maresch, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2022
Gene expression-based prediction of pazopanib efficacy in sarcomaChristoph E Heilig, Andreas Laßmann, Sadaf S Mughal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2022
Bcl-x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinomaPaula Hoffmeister-Wittmann, Andreas Mock, Federico Nichetti, et al.
Pageof 51